Determination of oligosaccharides in Pompe disease by electrospray ionization tandem mass spectrometry

Clinical Chemistry

Volumn 48, Issue 1, 2002, Pages 131-139

  Rozaklis, T ^a   Ramsay, S L ^a   Whitfield, P D ^a   Ranieri, E ^a   Hopwood, J J ^a   Meikle, P J ^a  

^a WOMEN S AND CHILDREN S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

1 PHENYL 3 METHYL 5 PYRAZOLONE; BIOCHEMICAL MARKER; CREATININE; GLUCOSE; OLIGOSACCHARIDE; PYRAZOLONE DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD ANALYSIS; CARBOHYDRATE ANALYSIS; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; GLYCOGEN STORAGE DISEASE TYPE 2; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; LYSOSOME STORAGE DISEASE; PATIENT MONITORING; TANDEM MASS SPECTROMETRY; URINALYSIS;

EID: 0036137877     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/48.1.131     Document Type: Article

References (28)

1. Glycogen storage disease type II: Acid α-glucosidase (acid maltase) deficiency
2. Molecular genetic study of Pompe disease in Chinese patients in Taiwan
3. Novel mutations in African American patients with glycogen storage disease type II
4. Prevalence of lysosomal storage disorders
5. Carrier frequency for glycogen storage disease type II in New York and estimates of affected individuals born with the disease
6. Frequency of glycogen storage disease type II in The Netherlands: Implications for diagnosis and genetic counselling
7. Clinical and metabolic correction of Pompe disease by enzyme therapy in acid maltase-deficient quail
8. Towards a molecular therapy for glycogen storage disease type II (Pompe disease)
9. Recombinant human acid α-glucosidase: High level production in mouse milk, biochemical characteristics, correction of enzyme deficiency in GSDII KO mice
10. Human acid α-glucosidase from rabbit milk has therapeutic effect in mice with glycogen storage disease type II
11. Retroviral transfer of acid α-glucosidase cDNA to enzyme-deficient myoblasts results in phenotypic spread of the genotypic correction by both secretion and fusion
12. Complete correction of acid α-glucosidase deficiency in Pompe disease fibroblasts in vitro, and lysosomally targeted expression in neonatal rat cardiac and skeletal muscle
13. Adenovirus-mediated transfer of the acid α-glucosidase gene into fibroblasts, myoblasts and myotubes from patients with glycogen storage disease type II leads to high level expression of enzyme and corrects glycogen accumulation
14. Approach to gene therapy of glycogenosis type II (Pompe disease)
15. Modulation of disease severity in mice with targeted disruption of the acid α-glucosidase gene
16. Determination of acid α-glucosidase protein: Evaluation as a screening marker for Pompe disease and other lysosomal storage disorders
17. Determination of acid α-glucosidase activity in blood-spots as a diagnosis for Pompe disease
18. Increased excretion of a glucose-containing tetrasaccharide in the urine of a patient with glycogen storage disease type II (Pompe's disease)
19. Quantitation of a urinary tetrasaccharide by gas chromatography and mass spectrometry
20. Increased urinary excretion of a glucose-containing tetrasaccharide in patients with Duchenne muscular dystrophy
21. Quantitation of some urinary oligosaccharides during pregnancy and lactation
22. Liquid chromatographic assay for a glucose tetrasaccharide, a putative biomarker for the diagnosis of Pompe disease
23. A new non-equilibrium enzyme linked immunosorbent assay for a glycogen-derived urinary tetrasaccharide
24. High-performance liquid chromatography of reducing carbohydrates as strongly ultraviolet-absorbing and electrochemically sensitive 1-phenyl-3-methyl-5-pyrazolone derivatives
25. Oligosaccharide characterization and quantitation using 1-phenyl-3-methyl-5-pyrazolone derivatization and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry
26. Electrospray ionization mass spectrometry of 1-phenyl-3-methyl-5-pyrazolone derivatives of neutral and N-acetylated oligosaccharides
27. HPLC analysis of oligosaccharides in urine from oligosaccharidosis patients
28. Urinary excretion of a glucose-containing tetrasaccharide. A parameter for increased degradation of glycogen